In bone, SLCO2B1 has been detected in both benign and malignant tumours, with significantly higher mRNA levels in aneurysmal bone cysts (benign) as compared with osteosarcomas (malignant) [19]. This evidence concerns the gene SLCO2B1 and cancer.